Ernst Wagner

Active 1988–2026

192
Papers
29,909
Citations
97
h-index
183
i10-index

Citations

Citations per year for Ernst Wagner1989: 1 citations1990: 6 citations1991: 17 citations1992: 57 citations1993: 93 citations1994: 111 citations1995: 178 citations1996: 106 citations1997: 95 citations1998: 212 citations1999: 267 citations2000: 286 citations2001: 293 citations2002: 249 citations2003: 304 citations2004: 273 citations2005: 300 citations2006: 238 citations2007: 333 citations2008: 280 citations2009: 284 citations2010: 354 citations2011: 365 citations2012: 309 citations2013: 217 citations2014: 189 citations2015: 213 citations2016: 168 citations2017: 224 citations2018: 196 citations2019: 525 citations2020: 568 citations2021: 606 citations2022: 486 citations2023: 348 citations2024: 582 citations2025: 299 citations2026: 15 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,881 citing papers, 24.3% of this breakdownChina: 1,170 citing papers, 15.1% of this breakdownGermany: 657 citing papers, 8.5% of this breakdownUnited Kingdom: 343 citing papers, 4.4% of this breakdownJapan: 305 citing papers, 3.9% of this breakdownFrance: 267 citing papers, 3.4% of this breakdownIndia: 230 citing papers, 3% of this breakdownSouth Korea: 223 citing papers, 2.9% of this breakdownCanada: 200 citing papers, 2.6% of this breakdownNetherlands: 180 citing papers, 2.3% of this breakdownItaly: 173 citing papers, 2.2% of this breakdownAustralia: 167 citing papers, 2.2% of this breakdown
0%24.3%Other 25.2%

Fields

  • Biochemistry, Genetics and Molecular Biology65.2%
  • Medicine12.6%
  • Materials Science9.7%
  • Immunology and Microbiology3.5%
  • Engineering3.1%
  • Chemistry1.6%
  • Other4.3%

Topics

  • RNA Interference and Gene Delivery18.6%
  • Advanced biosensing and bioanalysis techniques11.9%
  • Virus-based gene therapy research6.9%
  • Nanoparticle-Based Drug Delivery4.6%
  • Nanoplatforms for cancer theranostics2.1%
  • Immunotherapy and Immune Responses1.7%
  • Other54.2%

Coauthors

All papers

Open in search
  1. Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)

    Authors: , - Chemical Reviews 2015 cited by 594

  2. From structural design to delivery: mRNA therapeutics for cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , - Exploration 2023 cited by 105

  3. Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP

    Authors: , , - Biomaterials Science 2022 cited by 118

  4. Folate Receptor‐Mediated Delivery of Cas9 RNP for Enhanced Immune Checkpoint Disruption in Cancer Cells

    Authors: , , , , , , , , - Small 2022 cited by 55

  5. Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy

    Authors: , , , , , , , , , , - Acta Pharmacologica Sinica 2024 cited by 48

  6. Dynamic carriers for therapeutic RNA delivery

    Authors: , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2024 cited by 52

  7. Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery

    Authors: , - Pharmaceutical Research 2022 cited by 41

  8. Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and Polyplexes

    Authors: , , , , , , , , , , , - Advanced Materials 2023 cited by 40

  9. A Multistage Cooperative Nanoplatform Enables Intracellular Co‐Delivery of Proteins and Chemotherapeutics for Cancer Therapy

    Authors: , , , , , , , - Advanced Materials 2020 cited by 143

  10. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes

    Authors: , - Journal of Controlled Release 2022 cited by 54

  11. Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery

    Authors: , , , , , , - Journal of the American Chemical Society 2023 cited by 38

  12. Polyplex Evolution: Understanding Biology, Optimizing Performance

    Authors: , , , , - Molecular Therapy 2017 cited by 192

  13. Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer

    Authors: , , , , , , , - Journal of Controlled Release 2021 cited by 44

  14. Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers

    Authors: , - Journal of Controlled Release 2011 cited by 328

  15. Solid‐Phase Synthesis of Sequence‐Defined T‐, i‐, and U‐Shape Polymers for pDNA and siRNA Delivery

    Authors: , , , , , , , , , , , , , , - Angewandte Chemie International Edition 2011 cited by 195

  16. Polymeric Carriers for Nucleic Acid Delivery: Current Designs and Future Directions

    Authors: , - Biomacromolecules 2019 cited by 96

  17. In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting

    Authors: , , , , , , , , , , , - Small 2024 cited by 34

  18. PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

    Authors: , , , , - Gene Therapy 1999 cited by 1,172

  19. Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo

    Authors: , , , , , , - The Journal of Gene Medicine 2001 cited by 693

  20. Strategies and mechanisms for endosomal escape of therapeutic nucleic acids

    Authors: , - Current Opinion in Chemical Biology 2024 cited by 62

  21. Simple Modifications of Branched PEI Lead to Highly Efficient siRNA Carriers with Low Toxicity

    Authors: , , , - Bioconjugate Chemistry 2008 cited by 466

  22. Multifunctional Nanoparticles by Coordinative Self-Assembly of His-Tagged Units with Metal–Organic Frameworks

    Authors: , , , , , , , , , , - Journal of the American Chemical Society 2017 cited by 212

  23. Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach

    Authors: , - Advanced Drug Delivery Reviews 2020 cited by 82

  24. Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides

    Authors: , , , , , , , , - Bioconjugate Chemistry 2020 cited by 53